MELANIE FLETCHER: Open Payments
NPI 1780277426 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,820 in 103 payments from 20 companies in 2025. Trend: 2023 $526 · 2024 $1,973 · 2025 $2,820
Food & beverage: $2,496Travel & lodging: $324
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $570 |
| Medtronic, Inc. | 8 | $567 |
| ABBVIE INC. | 20 | $343 |
| Madrigal Pharmaceuticals | 5 | $226 |
| GENZYME CORPORATION | 7 | $181 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $161 |
| Lilly USA, LLC | 8 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $127 |
| Ardelyx, Inc. | 5 | $111 |
| Ipsen Biopharmaceuticals, Inc | 4 | $109 |
Products named: TREMFYA, VISUALASE, REZDIFFRA, DUPIXENT, XIFAXAN, OMVOH, CREON, LINZESS.
Industry payments across FL — which companies pay providers there.
